Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
3BBLACKBIO Stock Analysis
Views
Red Flags
Positive
High and stable ROE
Moderate revenue growth and above median growth of industry
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Low dividend yield
Neutral
High operating margin but declining trend
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
3BBLACKBIO Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
3BBLACKBIO Bulk, Block & Insider Trades
3BBLACKBIO Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
3B Blackbio DX Limited is an India-based company, which is engaged in the field of polymerase chain reaction (PCR)-based Molecular Diagnostic Kits. Its segments include Agrochemicals and Diagnostic kits. The diagnostics division of the Company is engaged in Design, Development Manufacturing and Comm... Read More
Key personnel
Shri. Dhirendra K. DubeyD
Chairman of the Board, Managing Director
Mrs. Navneet Kaur
Compliance Officer, Company Secretary
Shri. Nikhil K. DubeyD
Whole Time Director
Mrs. Mithila DubeyD
Non-Executive Director
Mr. Abdul Moin KhanD
Non-Executive Independent Director
Shri. Vivek SaihgalD
Non-Executive Independent Director
Mr. Harihar Prasad ThapakD
Non-Executive Independent Director
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of 3B Blackbio Dx Ltd.?
The current share price of 3B Blackbio Dx Ltd. is ₹ 1,454.80 as of 09 Jan 2026.
What is the PE ratio of 3B Blackbio Dx Ltd.?
The Price-to-Earnings (PE) ratio of 3B Blackbio Dx Ltd. is 25.24 as of the latest financial data.
What is the ROE and ROCE of 3B Blackbio Dx Ltd.?
3B Blackbio Dx Ltd. has a Return on Equity (ROE) of 18.16% and a Return on Capital Employed (ROCE) of 19.70% as per the latest financial reports.
What is the market cap of 3B Blackbio Dx Ltd.?
The market capitalization of 3B Blackbio Dx Ltd. stands at ₹ 1,248.65 Cr.
What is the dividend yield of 3B Blackbio Dx Ltd.?
The dividend yield of 3B Blackbio Dx Ltd. is 0.27% based on the current market price.
What is the RSI of 3B Blackbio Dx Ltd.?
The Relative Strength Index (RSI) of 3B Blackbio Dx Ltd. is 57.28.
What is the FII and DII holding in 3B Blackbio Dx Ltd.?
Foreign Institutional Investors (FII) hold 2.57% and Domestic Institutional Investors (DII) hold 0.00% of 3B Blackbio Dx Ltd. shares.
What sector does 3B Blackbio Dx Ltd. belong to?
3B Blackbio Dx Ltd. operates in the Chemicals sector.
What is the beta of 3B Blackbio Dx Ltd. stock?
The beta of 3B Blackbio Dx Ltd. stock is 0.95, indicating its volatility relative to the broader market.
